No relationship between −141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study
- 19 February 2001
- journal article
- clinical trial
- Published by Elsevier BV in Psychiatry Research
- Vol. 101 (1), 33-38
- https://doi.org/10.1016/s0165-1781(00)00247-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- No relationship betweenTaq1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary studyAmerican Journal of Medical Genetics, 2000
- Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteersMolecular Psychiatry, 1999
- Characteristics and Risk Factors of Acute Dystonia in Schizophrenic Patients Treated With Nemonapride, a Selective Dopamine AntagonistJournal of Clinical Psychopharmacology, 1999
- High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection.Journal of Chromatography B: Biomedical Sciences and Applications, 1998
- The D2 Dopamine Receptor GeneAlcohol, 1998
- Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophreniaBiological Psychiatry, 1997
- A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophreniaHuman Molecular Genetics, 1997
- Adverse Effects of Zotepine and Their Relationship To Serum Concentrations of the Drug and ProlactinTherapeutic Drug Monitoring, 1994
- Determination of bromperidol in serum by automated column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- A Survey of Drug-Induced Extrapyramidal ReactionsJAMA, 1961